[Hyderabad, 20 June 2025] – According to a recent industry analysis, the Asia-Pacific Continuous Bioprocessing Market is on a strong growth trajectory, poised to reach USD 2.4 billion by 2032, expanding at a robust CAGR of 17.1% from 2024 to 2032. This surge is attributed to increasing investments in biopharmaceutical R&D, a growing biosimilar market, and the urgent need for scalable,...
